[ CAS No. 82241-22-3 ] {[proInfo.proName]}

Name: 82241-22-3|2-Methyl-4-(piperazin-1-yl)quinoline|97%
Brand: Ambeed
SKU: A860507
Price: 22.0 USD
Availability: InStock
Rating: 92 (32 reviews)

,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

2D 3D

Structure of 82241-22-3 * Storage: {[proInfo.prStorage]}

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 110K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 82241-22-3 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 82241-22-3 ]

SDS Specification

Alternatived Products of [ 82241-22-3 ]

Product Details of [ 82241-22-3 ]

CAS No. :	82241-22-3	MDL No. :	MFCD01935745
Formula :	C₁₄H₁₇N₃	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	XYBLCORUTWKJOI-UHFFFAOYSA-N
M.W :	227.30	Pubchem ID :	702318
Synonyms :

Calculated chemistry of [ 82241-22-3 ]

Physicochemical Properties

Num. heavy atoms :	17
Num. arom. heavy atoms :	10
Fraction Csp3 :	0.36
Num. rotatable bonds :	1
Num. H-bond acceptors :	2.0
Num. H-bond donors :	1.0
Molar Refractivity :	78.07
TPSA :	28.16 Å²

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	Yes
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	Yes
CYP3A4 inhibitor :	Yes
Log Kp (skin permeation) :	-6.05 cm/s

Lipophilicity

Log Po/w (iLOGP) :	2.4
Log Po/w (XLOGP3) :	2.31
Log Po/w (WLOGP) :	1.19
Log Po/w (MLOGP) :	1.72
Log Po/w (SILICOS-IT) :	2.58
Consensus Log Po/w :	2.04

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-3.07
Solubility :	0.192 mg/ml ; 0.000844 mol/l
Class :	Soluble
Log S (Ali) :	-2.54
Solubility :	0.656 mg/ml ; 0.00289 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-4.59
Solubility :	0.00582 mg/ml ; 0.0000256 mol/l
Class :	Moderately soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	1.8

Safety of [ 82241-22-3 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P280-P305+P351+P338-P310	UN#:	N/A
Hazard Statements:	H302-H315-H319-H332-H335	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 82241-22-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Downstream synthetic route of [ 82241-22-3 ]

[ 82241-22-3 ] Synthesis Path-Downstream 1~21

1
[ 4295-06-1 ]
[ 6091-62-9 ]
[ 82241-22-3 ]

Reference： [1]Journal of the Chemical Society,1930,p. 1356,1358

2
[ 157898-12-9 ]
[ 82241-22-3 ]
phenyl 4-(2-methylquinolin-4-yl)piperazine-1-carboxylate [ No CAS ]

Reference： [1]Journal of the American Chemical Society,2007,vol. 129,p. 9594 - 9595

4
[ 187219-34-7 ]
[ 82241-22-3 ]
[ 946156-78-1 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2007,vol. 17,p. 3988 - 3991

5
[ 82241-22-3 ]
[ 124-63-0 ]
[ 1370280-36-6 ]

Yield	Reaction Conditions	Operation in experiment
	With triethylamine; In dichloromethane;Cooling with ice;	Step C: 2-Methyl-4-(4-methylsulfonylpiperazin-1-yl)quinoline2-Methyl-4-piperazin-1-yl-quinoline (227.3 mg, 1 mmol) was dissolved in anhydrous dichloromethane (7 ml), triethylamine was added (209 muIota, 1.5 mmol), followed by methanesulfonyl chloride (85 muIota, 1.1 mmol) which was added dropwise with ice-cooling. The mixture was diluted with dichloromethane and washed with 5% sodium bicarbonate solution. The wash solution was extracted with dichloromethane, the organic phases were combined and washed with 5% sodium bicarbonate solution, water and dried over magnesium sulfate. After evaporation of the solvent under reduced pressure 265 mg of a white foam were obtained (0.87 mmol, 87%) which was used directly in the next step.

Reference： [1]Patent: WO2012/41872,2012,A1 .Location in patent: Page/Page column 83

6
[ 4295-06-1 ]
[ 82241-22-3 ]

Reference： [1]Patent: WO2012/41872,2012,A1

7
[ 110-85-0 ]
[ 4295-06-1 ]
[ 82241-22-3 ]

Yield	Reaction Conditions	Operation in experiment
	In 2-ethoxy-ethanol; at 140℃;	Step B: 2-Methyl-4-piperazin-1-yl-quinoline4- Chloro-2-methylquinoline (1.8 g, 10 mmol) and anhydrous piperazine (5.25 g, 60 mmol) were dissolved in ethyleneglycol monoethylether (15 ml) and stirred at 140C overnight. The mixture was concentrated under reduced pressure, toluene was added (2 x 100 ml) and the solvent removed under reduced pressure. To the residue was was added 0.5 M NaOH (100 ml) and the mixture was extracted with a mixture of dichloromethane / diethylether / ethyl acetate (1 : 1 : 1 , 3 x 100 ml). The combined organic phases were washed with brine, dried over sodium sulfate and the solvent was removed under reduced pressure. 2.78 g of an off-white solid (8.5 mmol, 85%) were obtained that were used directly in the next step.

Reference： [1]ACS Medicinal Chemistry Letters,2013,vol. 4,p. 1005 - 1010
[2]Patent: WO2012/41872,2012,A1 .Location in patent: Page/Page column 91

8
[ 82241-22-3 ]
[ 1370275-97-0 ]

Reference： [1]Patent: WO2012/41872,2012,A1

9
[ 82241-22-3 ]
[ 1370271-05-8 ]

Reference： [1]Patent: WO2012/41872,2012,A1

10
[ 82241-22-3 ]
[ 1370280-37-7 ]

Reference： [1]Patent: WO2012/41872,2012,A1

11
[ 82241-22-3 ]
[ 33698-85-0 ]
[ 1370264-27-9 ]

Yield	Reaction Conditions	Operation in experiment
88%	With triethylamine; In dichloromethane; for 0.25h;	Step A: (£)-1-[4-(2-Methyl-4-quinolyl)piperazin-1-yl]pent-2-en-1-one2-Methyl-4-piperazin-1-yl-quinoline (1 13.7 mg, 0.5 mmol) was dissolved in anhydrous dichloromethane (1 ml), TEA (77 muIota, 0.5 mmol) followed by (£)-pent-2-enoyl chloride (65 mg, 0.55 mmol dissolved in 1 ml anhydrous dichloromethane) were added and the mixture was shaken for 15 minutes. The mixture was diluted with dichloromethane, washed with 5% sodium bicarbonate solution and water and the organic phase was evaporated to dryness under reduced pressure. The residue was purified by preparative HPLC (gradient of water containing 0.1 % NH3 and acetonitrile) to yield 143 mg of a solid (0.44 mmol, 88%). MS (ES): m/z = 354.2 [M+1]+.

Reference： [1]Patent: WO2012/41872,2012,A1 .Location in patent: Page/Page column 102-103

12
[ 1871-67-6 ]
[ 82241-22-3 ]
[ 1370264-32-6 ]

Yield	Reaction Conditions	Operation in experiment
77%		Example 17: Synthesis of (£)-1-[4-(2-methyl-4-quinolyl)piperazin-1-yl]oct-2-en-1-one (A- 14)(£)-Oct-2-enoic acid (71.1 mg, 0.5 mmol) was dissolved in dichloromethane (1 ml) and a 2M solution of oxalyl chloride in dichloromethane was added (0.3 ml, 0.6 mmol). The solution was stirred at room temperature for one hour after which a drop of DMF was added. Stirring was continued for another hour, the mixture was evaporated to dryness under reduced pressure. The residue was dissolved in dichloromethane (1 ml), the resulting solution was added to a solution of <strong>[82241-22-3]2-methyl-4-piperazin-1-yl-quinoline</strong> (103 mg, 0.45 mmol) and triethylamine (90muIota, 0.64 mmol) in dichloromethane (1 ml). The resulting mixture was stirred at room temperature overnight, diluted with dichloromethane (1 ml), washed with water and 2M NaOH (2 ml each) and evaporated to dryness under reduced pressure. The residue was purified by preparative HPLC (gradient of water containing 0.1 % ammonia and acetonitrile) to yield 121.3 mg of a solid (0.34 mmol, 77%).

Reference： [1]Patent: WO2012/41872,2012,A1 .Location in patent: Page/Page column 100-101

13
[ 32748-41-7 ]
[ 82241-22-3 ]
[ 1370266-01-5 ]

Reference： [1]Patent: WO2012/41872,2012,A1

14
[ 32748-41-7 ]
[ 82241-22-3 ]
[ 1370266-00-4 ]

Yield	Reaction Conditions	Operation in experiment
65%		Step C: (£)-4-Hydroxy-1-[4-(2-methyl-4-quinolyl)piperazin-1-yl]pent-2-en-1-one (A-178) (£)-4-Hydroxypent-2-enoic acid (67 mg, 0.52 mmol) was dissolved in anhydrous DMF (2.5 ml), DCC (107.5, 0.52 mmol) and HOAt (106.7 mg, 0.79 mmol) were added and the mixture was stirred at room temperature for 15 minutes. 2-Methyl-4-piperazin-1-yl- quinoline (118.2 mg, 0.52 mmol) was added and stirring was continued for 90 minutes. The mixture was evaporated to dryness, taken up in a mixture of acetonitrile and methanol and filtered. The filtrate was evaporated to dryness again and purified by preparative HPLC (gradient of water containing 0.1 % TFA and acetonitrile). 1 10 mg were obtained (0.33 mmol, 65%). MS (ES): m/z = 326.1 [M+1]+.

Reference： [1]Patent: WO2012/41872,2012,A1 .Location in patent: Page/Page column 92

15
tert-butyl 4-(2-methylquinolin-4-yl)piperazine-1-carboxylate [ No CAS ]
[ 82241-22-3 ]

Yield	Reaction Conditions	Operation in experiment
69%		Step B: 2-Methyl-4-piperazin-1-yl-quinolineTo te/f-butyl 4-(2-methyl-4-quinolyl)piperazine-1-carboxylate (4.382 g, 13.38 mmol) was added 40 ml of a 1 : 1 mixture of dichloromethane and trifluoroacetic acid. The mixture was stirred at room temperature for 15 minutes. The mixture was evaporated to dryness under reduced pressure and the residue dissolved in dichloromethane. The solution was washed with 5% sodium bicarbonate solution and 3M NaOH was added until the aqueous phase remained basic. The phases were separated, the aqueous phase was extracted twice with dichloromethane, the combined organic phases were washed with saturated sodium carbonate solution, water, dried over magnesium sulfate and evaporated to dryness. 2.1 g of a solid were obtained (9.25 mmol, 69%). MS (APCI): m/z = 227.8 [M+1]+.

Reference： [1]Patent: WO2012/41872,2012,A1 .Location in patent: Page/Page column 83

16
[ 401564-36-1 ]
[ 82241-22-3 ]
[ 401567-56-4 ]

Yield	Reaction Conditions	Operation in experiment
		General procedure: To a solution of 7a (450 mg, 1.50 mmol), 1-(4-chloroisoquinolin-1-yl)piperazine (446 mg, 1.80 mmol) and acetic acid (0.090 mL, 1.6 mmol) in 1,2-dichloroethane (8 mL) was added sodium triacetoxyborohydride (636 mg, 3.00 mmol) and the mixture was stirred at room temperature for 3 h. The reaction mixture was poured into a saturated aqueous sodium hydrogen carbonate solution and extracted with chloroform. The extract was washed with brine, dried and concentrated under reduced pressure. The residue purified by silica gel chromatography with chloroform/methanol (50:1, v/v) to give 3-{(2S,4S)-1-tert-butoxycarbonyl-4-[4-(4-chloroisoquinolin-1-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine (596 mg, 75%) as a white powder.The above compound (592 mg, 1.11 mmol) was dissolved in 1.1 mol/L hydrogen chloride in methanol (10 mL), and the mixture was stirred at room temperature for 5 days. The reaction mixture was concentrated under reduced pressure, and the residue was crystallized with ethanol to give the title compound (318 mg, 52%) as a pale-yellow powder.

Reference： [1]Bioorganic and Medicinal Chemistry,2012,vol. 20,p. 5033 - 5041

17
[ 3185-73-7 ]
[ 82241-22-3 ]
[ 1420814-46-5 ]

Yield	Reaction Conditions	Operation in experiment
0.2973 g	With N-ethyl-N,N-diisopropylamine; In tetrahydrofuran; dichloromethane; at 20℃;	To a solution of triphosgene (0.099 g, 0.33 mmol, 0.33 eq) in CH2Cl2 (10 mL), was slowly added 4-hydroxybiphenyl (0.1702 g, 1 mmol, 1 eq) and N,N-diisopropylethylamine (DIEA) (176 muL, 0.130 g, 1 mmol, 1 eq) as a solution in THF (10 mL). The reaction was stirred at room temperature for 30 min to generate the intermediate chloroformate. In a separate flask containing CH2Cl2 (10 mL), 2-methyl-4- piperazinoquinoline (0.3410 g, 1.5 mmol, 1.5 eq) was mixed with DIEA (263 muL, 0.195 g, 1.5 mmol, 1.5 eq). The mixture was stirred for 5 min at room temperature and then dropped into the flask containing the chloroformate. The reaction mixture was stirred at room temperature for another 30 min and partitioned between CH2Cl2 (50 mL) and saturated NH4Cl (50 mL). The organic layer was washed one more time with saturated NH4Cl (30 mL), dried over MgSO4 and filtered. The solvent was removed by rotary evaporation and the product was purified by silica gel column chromatography (1:1 ethyl acetate/hexanes) to afford JMN4 (0.2973 g, 0.702 mmol, 70%).

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2013,vol. 23,p. 839 - 843

18
[ 3099-31-8 ]
[ 82241-22-3 ]
2-methyl-4-(4-(pyridin-3-ylmethyl)piperazin-1-yl)quinoline [ No CAS ]

Reference： [1]Angewandte Chemie - International Edition,2017,vol. 56,p. 9833 - 9836
Angew. Chem.,2017,vol. 129,p. 9965 - 9968,4

19
[ 82241-22-3 ]
(3-((4-(2-methylquinolin-4-yl)piperazin-1-yl)methyl)pyridin-4-yl)triphenylphosphonium trifluoromethanesulfonate [ No CAS ]

Reference： [1]Angewandte Chemie - International Edition,2017,vol. 56,p. 9833 - 9836
Angew. Chem.,2017,vol. 129,p. 9965 - 9968,4

20
[ 82241-22-3 ]
2-methyl-4-(4-((4-(p-tolyl)pyridin-3-yl)methyl)piperazin-1-yl)quinoline [ No CAS ]

Reference： [1]Angewandte Chemie - International Edition,2017,vol. 56,p. 9833 - 9836
Angew. Chem.,2017,vol. 129,p. 9965 - 9968,4

21
[ 82241-22-3 ]
[ 814-68-6 ]
1-(4-(2-methylquinolin-4-yl)piperazin-1-yl)prop-2-en-1-one [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
26%	With triethylamine; In dichloromethane; at 0 - 20℃;	A solution of 2-methyl-4-(piperazin-1-yl)quinolone (455 mg, 2.0 mmol) in DCM (20 mL) was cooled to 0 C. To the solution was added acryloyl chloride (217 mg, 2.4 mmol) followed by triethylamine (243 mg, 2.4 mmol). The solution was allowed to warm to room temperature and stirred overnight. The solution was washed with brine and the crude product was purified via basic alumina chromatography (100% ethyl acetate) to afford the product in 26% yield as a yellow oil (145 mg).1H NMR (400MHz, CDCl3): d 7.90-8.05 (m, 2H), 7.58-7.70 (ddd, J = 8.4, 6.8, 1.5 Hz, 1H), 7.40-7.50 (ddd, J = 8.2, 6.8, 1.3 Hz, 1H), 6.68-6.76 (s, 1H), 6.56-6.67 (dd, J = 16.8, 10.5 Hz, 1H), 6.30-6.40 (dd, J = 16.8, 2.0 Hz, 1H), 5.70-5.80 (dd, J = 10.5, 2.0 Hz, 1H), 3.70-4.06 (d, J = 54.7 Hz, 4H), 3.10-3.30 (t, J = 5.0 Hz, 4H), 2.62-2.72 (s, 3H).13C NMR (100MHz, CDCl3): d 165.5, 159.4, 156.2, 149.2, 129.26, 129.24, 128.3, 127.3, 124.9, 123.0, 121.6, 109.8, 52.3, 51.9, 45.8, 42.0, 25.6. HRMS (+ESI): Calculated: 282.17 (C17H19N3O). Observed: 282.1597.

Reference： [1]Cell Chemical Biology,2019,vol. 26,p. 1027 - 22,1035
[2]Patent: WO2020/76996,2020,A1 .Location in patent: Paragraph 0591; 0597

Same Skeleton Products

Related Products

Historical Records

Related Parent Nucleus of
[ 82241-22-3 ]

Piperazines

[ 1146293-27-7 ]

6-Chloro-2-methyl-4-(piperazin-1-yl)quinoline

Similarity: 0.91

[ 1707361-86-1 ]

1-(2-Methylpyridin-4-yl)piperazine trihydrochloride

Similarity: 0.85

[ 166954-07-0 ]

1-(2,6-Dimethylpyridin-4-yl)piperazine

Similarity: 0.85

[ 166954-05-8 ]

1-(2-Methylpyridin-4-yl)piperazine dihydrochloride

Similarity: 0.85

[ 118306-89-1 ]

4-(Piperazin-1-yl)quinoline

Similarity: 0.84

Quinolines

[ 81528-71-4 ]

N1-(2-Methylquinolin-4-yl)ethane-1,2-diamine

Similarity: 0.92

[ 1146293-27-7 ]

6-Chloro-2-methyl-4-(piperazin-1-yl)quinoline

Similarity: 0.91

[ 118306-89-1 ]

4-(Piperazin-1-yl)quinoline

Similarity: 0.84

[ 149144-32-1 ]

6-Methoxy-2-methyl-4-(piperazin-1-yl)quinoline

Similarity: 0.84

[ 175203-79-9 ]

4-(Piperazin-1-yl)-2-(trifluoromethyl)quinoline

Similarity: 0.82

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]}	{[ getRatePrice(item.pr_usd, 1,1) ]}	Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]}	{[ item.pr_usastock ]}	Inquiry -	{[ item.pr_chinastock ]}	Inquiry -

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

[ CAS No. 82241-22-3 ] {[proInfo.proName]}

Quality Control of [ 82241-22-3 ]

Related Doc. of [ 82241-22-3 ]

Product Details of [ 82241-22-3 ]

Calculated chemistry of [ 82241-22-3 ]

Physicochemical Properties

Pharmacokinetics

Lipophilicity

Druglikeness

Water Solubility

Medicinal Chemistry

Safety of [ 82241-22-3 ]

Application In Synthesis of [ 82241-22-3 ]

[ 82241-22-3 ] Synthesis Path-Downstream 1~21

Related Parent Nucleus of [ 82241-22-3 ]

Piperazines

Quinolines

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Related Parent Nucleus of
[ 82241-22-3 ]